pancreatitis and tirzepatide Fatal, Fulminant, Necrotizing Associated With Recent Initiation Mounjaro use is rising. But

As the medication become more available, experts said they worry about the impact of these weight loss products on eating disorders

13 Treatment in these cases was delayed until the presentation of normal blood glucose (BG) concentrations

Moderate weight loss was found to be a common side effect of the drug, and the FDA approved a different formulation of semaglutide, called Wegovy, for that purpose in 2021

We spent a lot of time in the community trying to understand what they needed, what they were scared of, and what they were excited about with the new development arriving

These treatments have been shown to significantly aid in weight loss and improve overall metabolic health, making them a true game-changer for individuals struggling with weight management